Penumbra Newsroom

Penumbra's Prospective Growth Amidst Market Dynamics Justifies Hold Rating

TipRanksNov 22 06:27 ET

Penumbra Is Maintained at Overweight by Piper Sandler

Dow JonesNov 20 13:13 ET

Penumbra Analyst Ratings

BenzingaNov 20 13:06 ET

Piper Sandler Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $250

Moomoo NewsNov 20 07:31 ET

Truist Financial Maintains Penumbra(PEN.US) With Buy Rating, Announces Target Price $240

Moomoo NewsNov 5 21:31 ET

Analysts Conflicted on These Healthcare Names: Penumbra (PEN), Kymera Therapeutics (KYMR) and NovoCure (NVCR)

TipRanksNov 5 07:42 ET

Penumbra (PEN) Receives a Buy From BTIG

TipRanksNov 5 05:30 ET

Penumbra's Strong Q3 2024 Performance and Future Growth Prospects Justify Buy Rating by William Plovanic

TipRanksNov 4 07:49 ET

A Quick Look at Today's Ratings for Penumbra(PEN.US), With a Forecast Between $232 to $248

Moomoo NewsNov 1 09:19 ET

A Quick Look at Today's Ratings for Penumbra(PEN.US), With a Forecast Between $232 to $248

Moomoo NewsOct 31 09:20 ET

Penumbra Is Maintained at Outperform by Baird

Dow JonesOct 31 08:03 ET

Baird Maintains Outperform on Penumbra, Raises Price Target to $248

BenzingaOct 31 07:51 ET

Penumbra Analyst Ratings

BenzingaOct 31 07:51 ET

Penumbra Analyst Ratings

BenzingaOct 25 06:01 ET

Needham Maintains Penumbra(PEN.US) With Hold Rating

Moomoo NewsOct 25 05:33 ET

Penumbra's Thunderbolt Study Progress and Market Impact: Matson Maintains Hold Rating

TipRanksOct 25 05:18 ET

Piper Sandler Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $225

Moomoo NewsOct 18 07:31 ET

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG) and Penumbra (PEN)

TipRanksOct 18 06:42 ET

Penumbra Is Maintained at Buy by Canaccord Genuity

Dow JonesOct 16 14:17 ET

Penumbra Analyst Ratings

BenzingaOct 16 14:07 ET